• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 5, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Binghamton University’s Speech and Language Pathology program receives accreditation candidacy

Bioengineer by Bioengineer
March 19, 2024
in Health
Reading Time: 2 mins read
0
Binghamton University Master of Science in Speech and Language Pathology (MS-SLP)
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

BINGHAMTON, N.Y. — The new Master of Science in Speech and Language Pathology (MS-SLP) program at Binghamton University’s Decker College of Nursing and Health Sciences has achieved a significant milestone toward accreditation by the Council on Academic Accreditation in Audiology and Speech-Language Pathology (CAA). The council recently awarded the program accreditation candidacy for five years, beginning Feb. 1, 2024, and running through Jan. 31, 2029.

Binghamton University Master of Science in Speech and Language Pathology (MS-SLP)

Credit: Binghamton University, State University of New York

BINGHAMTON, N.Y. — The new Master of Science in Speech and Language Pathology (MS-SLP) program at Binghamton University’s Decker College of Nursing and Health Sciences has achieved a significant milestone toward accreditation by the Council on Academic Accreditation in Audiology and Speech-Language Pathology (CAA). The council recently awarded the program accreditation candidacy for five years, beginning Feb. 1, 2024, and running through Jan. 31, 2029.

The decision was based on a thorough review of all candidacy materials for the program, including the application, site visit report and the program’s correspondence throughout the review period. The CAA determined Binghamton’s MS-SLP program demonstrated sufficient compliance with the Standards for Accreditation, as outlined in the Standards Compliance Continuum.

“The Division of Speech and Language Pathology is pleased with the five-year initial accreditation outcome for our MS-SLP program,” said Rodney Gabel, founding director and professor. “I want to recognize the faculty and staff in the division for their hard work in developing the program, as well as the faculty and staff across Decker College and Binghamton University who made this possible. Earning accreditation candidacy speaks to the high-quality academic programs Binghamton is known for.”

Gabel added that the program has already begun recruiting students for its first cohort, which will start this fall.

“Receiving accreditation for the speech and language pathology program marks a significant milestone in Decker College’s commitment to providing exceptional healthcare education,” said Mario Ortiz, dean and professor. “We aim to provide our students with the knowledge and skills required for success in today’s constantly changing healthcare environment. This accomplishment reaffirms that goal.” 

Binghamton’s MS-SLP program will be included in all candidate program listings by the CAA. Award of candidacy allows the University to matriculate students into the program as it continues to document compliance with accreditation standards for the duration of the candidacy accreditation cycle.



Share12Tweet8Share2ShareShareShare2

Related Posts

Major Trial Finds Finerenone Slows Kidney Decline and Lowers Cardiovascular Risk in Non-Diabetic Chronic Kidney Disease

June 5, 2026

New Study Links Common Blood Pressure Medication to Worsened Kidney Outcomes in Type 2 Diabetes

June 5, 2026

Genomic Study Reveals Orofacial-Systemic Disease Links

June 5, 2026

How ‘Dad Bods’ Could Impact Childhood Obesity Risks: New Insights

June 4, 2026

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    321 shares
    Share 128 Tweet 80
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    88 shares
    Share 35 Tweet 22
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    75 shares
    Share 30 Tweet 19
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Major Trial Finds Finerenone Slows Kidney Decline and Lowers Cardiovascular Risk in Non-Diabetic Chronic Kidney Disease

New Study Links Common Blood Pressure Medication to Worsened Kidney Outcomes in Type 2 Diabetes

Breakthrough ‘Universal Vaccine’ Technology Promises Protection Against Future Virus Outbreaks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.